Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform.
Cumulus Neuroscience has raised $4.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
Cumulus Neuroscience's investors include Innovate UK, Dementia Discovery Fund, LifeArc, Whiterock Finance, ACF Investors.
Cumulus Neuroscience is headquartered in Belfast, United Kingdom.
Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform.
Cumulus Neuroscience is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cumulus Neuroscience — Funding & Investors." VCBacked, July 8, 2025, https://www.vcbacked.co/company/cumulus-neuroscience. Accessed July 20, 2026.
VCBacked. (2025). Cumulus Neuroscience — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/cumulus-neuroscience
{{cite web |title=Cumulus Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/cumulus-neuroscience |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated